Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 27 390 30 578 31 904 33 895 36 470 39 051
EBITDA 7 022 9 833 8 188 8 863 9 907 10 320
Operating profit (EBIT) 5 976 6 555 7 110 7 577 8 502 9 347
Pre-Tax Profit (EBT) 2 231 2 873 4 077 5 688 8 241 9 175
Net income 353 2 334 3 687 4 460 5 538 7 430
P/E ratio 285x 55,2x 42,2x 29,5x 24,1x 20,0x
EPS ( $ ) 0,20 1,31 2,06 2,52 3,10 3,73
Dividend per Share ( $ ) 1,08 1,16 1,32 1,42 1,56 1,71
Yield 1,88% 1,60% 1,52% 1,91% 2,09% 2,30%
Reference price ( $ ) 57,070 72,330 86,860 74,560 74,560 74,560
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 18 314 15 480 13 999 10 625 6 332 6 738
Finance - - - - - -
Operating income (EBITDA) 7 022 9 833 8 188 8 863 9 907 10 320
Leverage
(Debt/EBITDA)
2,61x 1,57x 1,71x 1,20x 0,64x 0,65x
Capital Expenditure 1 000 1 394 1 638 1 725 1 851 1 916
Free Cash Flow (FCF) 4 435 4 906 4 498 5 951 6 955 7 620
Book Value Per Share (BVPS) ( $ ) 17,7 17,4 17,6 23,0 24,5 16,4
Cash Flow per Share ( $ ) 3,18 3,56 3,45 4,57 - -
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 131 482 M $ -
Entreprise Value (EV) 142 106 M $ 137 813 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 29,5x 24,1x
Capitalization / Revenue 3,88x 3,61x
EV / Revenue 4,19x 3,90x
EV / EBITDA 16,0x 14,3x
Yield (DPS / Price) 1,91% 2,09%
Price to book (Price / BVPS) 3,24x 3,04x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 22,4% 23,3%
Operating Leverage (Delta EBIT / Delta Sales) 1,05x 1,61x
Net Margin (Net Profit / Revenue) 13,2% 15,2%
ROA (Net Profit / Asset) 8,09% 10,8%
ROE (Net Profit / Equities) 15,3% 17,6%
Rate of Dividend 56,4% 50,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   5,09% 5,08%
Cash Flow / Sales 23,8% -
Capital Intensity (Assets / Sales) 1,63x 1,41x
Financial Leverage (Net Debt / EBITDA) 1,20x 0,64x
EPS & Dividend